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ABSTRACT 
 
The increasing use of off-label category drugs is the reason clinicians use these drugs because the clinical response has not had a 
significant impact on treatment as well as various reasons for specific therapeutic purposes. While adverse events and adverse reactions 
to drugs from off-label category drugs tend to continue to increase, so we need continuous and continuous data and study of therapies 
about the use of off-label category drugs. The purpose of this study was to analyze the characteristics of usage patterns and reasons for 
administering off-label categories of drugs to inpatients in hospitals. This research was conducted at the hospital. Dr. Wahidin Sudiro 
Husodo Makassar. Research uses data in the form of inpatient prescriptions in the internal medicine, children's and obgin's sections with a 
prescription number of 150 sheets. The results showed that the indication of disease using off-label category drugs was not dominated by 
one particular disease but rather based on the needs and conditions of the disease and the drug availability of the off label drug. The pattern 
of treatment using off-label categories of drugs given orally is the most dominant given by the clinician. The type of drug that is commonly 
used in the off-label category is not dominated by certain classifications, but drugs with indicated anti-pain are the choices for the type of 
drug used. The reason the clinician decides to use off-label category drugs is because the on-label category drugs have not been able to 
contribute to healing the diagnosis of the disease while some drugs based on experience for drugs that have not been approved can provide 
a significant healing process. 
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INTRODUCTION 
Off-label drug use is the use of drugs outside the 
indications approved by the authorized agency. The 
use of off-label category drugs for therapeutic 
purposes must require a process of proving efficacy 
and risk of side effects so that when the drug is used 
for certain therapeutic purposes the drug is safe. 
While on-label category drugs are drugs that have 
a marketing authorization issued by BPOM or the 
Ministry of Health, on-label category drugs by the 
authorities can guarantee that drugs have been 
tested for safety, efficacy and quality so that risks 
can be overcome or minimized. The use of off-label 
category drugs can cause side effects and risks that 
may outweigh potential benefits. Ethical and legal 
issues relating to the promotion of commercial use 
of off-label drugs have also increased due to very 
fast information and in-depth technological studies 
on the use of off-label categories of drugs. Use 
outside the label has not been formally evaluated, 
and the evidence provided for one clinical situation 
may not apply to another person. The use of off-
label drugs, cannot be categorized as the use of 
drugs that violate the law or legal ethics, but can be 
categorized as use that is risky because it can 
cause adverse effects up to 23%. 3, 5, 15. The 
publication of Adriana 2017 research results in 
Brazil with prospective methods shows that 157 
newborns and 1187 prescriptions analyzed found 
that there were 56.0% of drugs in the off-label 
category and 7.2% of the illegal category recipes.1 
Documents released by the European survey 
agency EMEA in 2004 reported that there were 
serious adverse events for patients using off-label 
categories. 8. The increasing use of off-label 
category drugs is the reason clinicians use these 
drugs because the clinical response has not had a 
significant impact on treatment as well as various 
reasons for specific therapeutic purposes. While 
adverse events and adverse reactions to drugs from 
off-label category drugs tend to continue to 
increase, so we need continuous and continuous 
data and study of therapies about the use of off-
label category drugs. The use of off-label categories 
of drugs is often beneficial and provides new 
breakthroughs in treating certain cases of disease. 
It may be that clinical evidence of its efficacy 
already exists, but approval has not been requested 
from the competent authorities for various reasons. 
But it should also be noted that because this drug is 
used outside the indications written on the drug 
label, so if the drug has an undesirable effect, 
various reports of unwanted events give caution in 
using off-label category drugs. 
 
MATERIAL AND METHOD 
This research will be carried out at Wahidin Sudiro 
Husodo Hospital Makassar in April - November 
2018. This type of research is quantitative research 
with a cross-sectional study design. This study uses 
a survey method that is collecting prescription drugs 
that are categorized as off-label drugs in several 
departments in hospitals and then analyzing the 
relationship between variables. The population in 
this study was prescribing hospital doctors for 
inpatients and doctors who wrote prescription drugs 
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off-label categories. The sample size in this study 
used parameter estimation with data on the 
proportion of 150 prescription drugs for the off-label 
category. The sampling technique in this study was 
conducted by random sampling, which is choosing 
a prescription drug category off-label. Data 
processing and analysis techniques in this study 
use multivariate analysis methods that can be used 
to confirm whether the measurement analysis was 
built in accordance with what was hypothesized. 
 
 
 
RESULT 
This study is an observational study related to the 
use of off label categories for inpatients in hospitals. 
Wahidin Sudiro Husodo Hospital Makassar. 
Research results show that the use of off-label 
categories of drugs provides benefits to the 
development of therapy but on the other hand the 
threat of side effects and regulation of marketing 
authorization have not been obtained from the 
authorities. The results of the study related to the 
use of off label category drugs in patients receiving 
treatment at the Hospital Wahidin Sudiro Husodo 
Makassar
 
 
Table 1. Use of off-label categories of drugs related to dosage, route of administration and  
indications of drugs that affect the treatment process. 
No. Drugs Dosage Administration route Indication 
1 
Metronidazole tab 
500mg 
10 tablets made to 
powder 
Smeared on the wound 
surface 
Wound care 
2 
Metronidazole tab 
500mg 
10 tablets were crushed 
and dispersed in 
gentamicin ointment 
Smeared on the wound 
surface 
Wound care 
3 
Metronidazole tab 
500mg 
10 tablets were crushed 
and dispersed in fucidic 
acid ointment  
Smeared on the wound 
surface 
Wound care 
4 
Metronidazole 500 
mg/100 ml 
100 ml wash the wound Intrvena Wash the wound 
5 Aspar insulin 10 unit Intravena Hipercalemia 
6 
Metformin 500 mg 
tab  
500 mg/8 hours Oral 
Polycystic 
ovarium 
syndrome 
(PCOS) 
7 
Sucralfate susp 
100 ml 
100 ml wash the wound Oral 
Wash digestive 
wounds 
8 Captopril tab  6,25 mg/8 hours Oral Anti remodeling 
9 Chloroquine tab 
200 mg/24 hours 
250 mg/days (3,5-4 
mg/kg body weight 
/days) 
Oral  
Systemic Lupus 
Erythematosus 
(SLE)  
10 Laxative syrup 60 ml Rectal/clisma Anal cleansing 
11 Misoprostol tab 40 ug/dosage Pervaginal 
Labor 
Stimulating 
12 
Carbamazepine 
tab 
100 mg Oral Mood stabilizer  
13 Gabapentin tab 300 mg Oral  
Neuropathy 
therapy 
14 Risperidone tab 0,25 mg/12 hours Oral  
Overcoming 
hyperactivity 
disorders 
15 
Codein  
Paracetamol  
20 mg 
500 mg/made to powder 
Oral  Cancer pain 
16 
Amitriptyline 6,25 
mg 
Paracetamol 500 
mg 
Diazepam 1 mg 
Coffein 20 mg 
Made to powder Oral Overcome pain 
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17 
Cyproheptadine 
tab 
4 mg/8 hours Oral 
Increased 
appetite 
18 Zinkid tablet 50 mg Oral Wilson diseases 
19 Domperidon tab 10 mg Oral 
Breast milk 
stimulation 
 
Table 1 shows that the majority of off-label category 
drugs are used in oral form or the same as the drug 
administration approved by the authorities 
(BPOM/on label) but with different indications and 
characteristics of the disease. The category of off 
label drugs is drugs outside the indications listed on 
the label and not yet or outside approval by the 
authorized body or institution such as the BPOM or 
the FDA (Food Drug Administration). Reasons for 
using off label categories are lack of clinical 
response to previous treatment, intolerance or 
contraindications to alternatives or reasons such as 
the availability of approved drugs as indicated or 
patients with alternative treatments for clinical or 
logistical reasons. Factors of pharmacokinetic data, 
pharmacodynamics and drug side effects, which 
have not been optimal are other reasons for the use 
of off label categories of drugs. 
 
Table 2. The classification of pharmacotherapy and the reason doctors give prescriptions for  
the use of off-label categories of drugs 
 
No. Drugs 
Pharmacotherapy 
Classification 
Indications off 
label 
Reason doctors give off 
label category drugs 
1 
Metronidazole tab 
500mg 
Anaerobic/ 
antibacterials 
Antiinfection / 
Wound care 
Accelerate wound drying  
2 
Metronidazole tab 
500mg 
Anaerobic/ 
antibacterials 
Wound care Accelerate wound drying 
3 
Metronidazole tab 
500mg 
Anaerobic/ 
antibacterials 
Wound care Accelerate wound drying 
4 
Metronidazole tab 
500 mg/100 ml 
Accelerate wound 
drying 
Wound care 
Clean the wound so as 
to avoid infection 
5 Aspar insulin Antidiabetic Hyperkalemia 
Provided to patients who 
experience hyperkalemi 
in diabetic kidney 
disorders while in 
hospital  
6 
Metformin 500 mg 
tab 
Antidiabetic 
Polycystic 
ovarium 
syndrome 
Given to patients who 
have PCOS (Polycystic 
Ovary Syndrome) due to 
hormonal imbalance and 
increased hormone and 
ovulation disorders 
7 
Sucralfate susp 100 
ml 
Gastrointestinal 
disorders (ulcer 
drugs and 
inflammation of the 
stomach) 
Washing 
digestive 
wounds, the 
digestive tract 
used orally 
especially to 
treat active 
duodenal 
ulcers. 
Sucralfate is a 
cytoprotective 
agent 
Preventing the 
occurrence of stress 
ulcers in patients with 
gastroesophageal reflux 
disease (GERD) 
8 Captopril tab Antihypertensive 
Anti 
remodeling 
Reducing the risk of 
heart failure by 
preventing remodeling in 
the left ventricle of the 
heart (restoring the 
function / model of the 
left ventricle of the 
heart)  
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9 Chloroquine tab Antimalarians 
SLE (Systemic 
Lupus 
Erythematosus
) 
stabilization of the 
lysosomal membrane 
thereby inhibiting the 
release of lysosomal 
enzymes, binding to 
DNA, disrupting DNA 
antibody attacks, 
decreasing 
prostaglandin and 
leukotriene production, 
decreasing T cell 
activity, and releasing 
IL-1 and tumor 
necrosing factor α (TNF-
α). The aim is to 
improve the regression 
of erythema of skin 
lesions 
10 Laxative syrup Laxative 
Clisma/ 
levament 
Rectal cleansing for 
colonoscopy preparation 
11 Misoprostol 
Gastrointestinal 
disorders (gastric 
ulcer prevention 
drugs classified as 
prostaglandin E1 
synthesis) 
Labor 
Stimulating 
Shorter induction, 
progress 
delivery is faster 
12 Carbamazepine 
Overcoming 
seizures in epilepsy 
Mood stabilizer 
Improve the stability of 
the behavioral 
conditions 
13 Gabapentin 
Anti 
convulsions 
Neuropathy 
therapy 
Treatment in patients 
with impaired nerve 
function (tingling), feel 
punctured or painful  
14 Risperidone 
Medication to 
overcome 
psychiatric 
disorders 
(antipsychotics) 
Overcoming 
hyperactivity 
disorders 
Overcome behavioral 
disorders or 
hyperactivity and 
overcome anxiety 
15 
Codein 
Paracetamol 
Treatment of cough 
and fever 
Treatment of 
cancer pain 
The two drugs are 
different classes and 
mechanisms, but the 
combination of the two 
drugs can increase pain 
reduction significantly 
for cancer patients 
16 
Amitriptyline 6,25 
mg 
Paracetamol 500 mg 
Diazepam 1 mg 
Coffein 20 mg 
Analgetics Neuropathy 
Treatment of neuropathy 
(cramps) 
17 Cyproheptadine Antihistamin 
Increased 
appetite 
Increase appetite 
18 Zinkid tab 
Treatment for 
diarrhea 
Wilson 
diseases 
Maintain copper levels 
in the body, after 
spending excess copper 
in the body and prevent 
interference due to 
excess copper 
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19 Domperidon tab 
Treatment and 
prevention of 
vomiting 
Streamlining 
breast milk 
Stimulates the hormone 
prolactin so that it 
increases milk 
production 
 
Table 2 shows that pharmacotherapy of drugs used 
for off-label category drugs shows that doctors use 
or administer off-label category drugs. The table 
shows that the pharmacotherapy of the drug 
category is off label and the reason the doctor gives 
the drug indicates that desired therapy with different 
goals. The lack of clinical response and the use of 
active compounds from these drugs is a significant 
reason for the use of off label category drugs
 
 
DISCUSSION 
Treatment patterns, off-label category drugs used in 
hospital hospitals. Dr. Wahidin Sudiro Husodo 
Makassar, is something that cannot be avoided 
because the clinical response has not shown 
changes and the potential of active compounds of 
the drug that can be used for different therapies so 
that it is possible to be used, then other factors 
using off label categories are due to drug supply for 
use as a treatment is not available. 
Metronidazole is an antimicrobial class of 
nitroimidazole derivatives used to treat infections 
caused by protozoan microorganisms and 
anaerobic bacteria. The mechanism of action of 
Antibacterials in preventing the spread of infectious 
agents or killing infectious agents so they do not 
spread. Its mechanism of action is that it inhibits 
nucleic acid synthesis by damaging DNA. Table 1 
shows that metonidazole is used as an off label 
drug for wound healing. The reason it is used for the 
treatment and healing of wounds, methodidazole is 
given in powder and ointment mixed with 
gentamicin ointment and fucid acid ointment. The 
combination of these drugs is in the form of 
ointments that can facilitate penetration into the 
wound site. Tablet administration that should be 
administered orally is given in the form of toipical 
and a dose of 10 tablets crushed with 5000 mg 
active substance dispersed into gentamicin 
ointment or fucid acid ointment. The mechanism of 
action of metronidazole ointment for the purpose of 
wound care or wound drying is the reduction of 
inflammation or lesions and erythema perilesi7.  
A form of the type of fast-acting insulin hormone, 
insulin works by reducing blood sugar levels. Aspart 
insulin is used to treat type 1 (insulin-dependent) 
diabetes in adults and children who are at least 2 
years old. The drug is used as an off label drug for 
patients with hyperkalemia, which is the 
accumulation of potassium in the blood. The 
mechanism of action of the drug is to push and 
move potassium into the cell and stimulate 
absorption by the cell membrane. 
Metformin is one of the biguanid antidiabetic groups 
with the aim of controlling high blood sugar, usually 
used by people with type 2 diabetes. Metmorphine 
works by helping to restore the body's proper 
response to naturally produced insulin. For women 
who experience hormonal disorders that cause 
polycystic ovary syndrome (PCOS / PCOS) are 
metabolic disorders associated with irregular 
menstrual cycles, hormonal imbalances, and insulin 
resistance problems. Insulin resistance is a 
condition where the body's cells stop reacting to 
normal insulin levels, the condition is found in 
women suffering from PCOS and ovulation 
problems. Metformin as an off label category drug 
is used to overcome insulin resistance by regulating 
reproductive hormones and restoring ovulation and 
helping to ovulate. The use of metformin can make 
the menstrual cycle more orderly and the process 
of ovulation can be controlled. 
Sucralfate syrup is an indigestion drug to treat and 
prevent gastric ulcer and duodenal ulcer. This drug 
works by forming a layer on the wound and protect 
it from stomach acid which can slow healing. The 
use of Sukralfat for the off label category is washing 
wounds in patients who have duodenal ulcers 
Captopril is a drug to treat high blood pressure 
(hypertension) which is included in the ACE 
inhibitors class. This drug works by inhibiting the 
angiotensin-converting enzyme which then 
decreases the amount of angiotensin II (a hormone 
that causes blood vessel constriction and increases 
blood pressure). The use of captoril for the off label 
category is as an antiremodeling, a condition where 
there is a decrease in the function of the heart pump 
so that the heart undergoes cell remodeling through 
a variety of complex biochemical mechanisms and 
ultimately decreases heart function, this is due to 
myocardial infarction conditions, chronic 
hypertension, and cardiomyopathy6.  
Chloroquine is a drug used to prevent and treat 
malaria, or treat infectious diseases caused by 
mosquitoes infected with parasites. Chloroquine 
works in the erythrocyte phase and is not effective 
in the hepatic phase. The use of Chloroquine for the 
off label category is as a treatment for Systemic 
Lupus Erythematosus (SLE), stabilization of the 
lysosome membrane thereby inhibiting the release 
of lysosomal enzymes, binding to DNA, disrupting 
DNA antibody attacks, decreasing prostaglandin 
and leukotriene production, decreasing T cell 
activity, and releasing IL-1 and tumor necrosing 
factor α (TNF-α). The aim is to improve the 
regression of erythema of skin lesions. 
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Laxatives (Phenolphtalein. Liquid paraffin, Glycerin) 
action by stimulating peristalsis in the large intestine 
and inhibiting the absorption of excess water from 
feces and smoothing out the feces. The use of 
laxatives for the off label category is as clisma or 
lavement for sufferers to be colonoscopy. 
Misoprostol is a gastrointestinal drug used to 
prevent and treat peptic ulcers, prevent ulcers in the 
small intestine. Misoprostol works to reduce acid 
levels in the stomach, and increase levels of mucus 
and bicarbonate in the stomach. The use of 
misoprostol for the off label category is. Misoprostol 
has been extensively studied in reproductive health, 
and is widely recommended for the treatment of 
missed and incomplete miscarriages, abortion 
induction, and cervical preparation before uterine 
instrumentation, labor induction and prophylaxis of 
postpartum hemorrhage and treatment. The use of 
misoprostol for off-label indications is to induce 
labor. Misoprostol is a prostaglandin class that 
works to ripen the cervix and is given intravaginally. 
Carbamazepine is a drug used to prevent and 
control seizures or convulsions. These drugs are 
included in the class of anticonvulsant drugs or 
antiepileptic drugs. Carbamazepine drug is a drug 
used to treat epilepsy and neuropathy patients. 
Carbamazepine also treats certain mental or mood 
conditions such as bipolar disorder. 
Gabapentin is an anticonvulsant drug that functions 
to treat seizures, works by affecting the nervous 
system, clinicians give gabapentin with a diagnosis 
of anti-convulsions or antiepilepsy. 
The interaction of gabapentin and morphine can 
increase gabapentin levels in blood plasma. 
Whereas with antacids can reduce the absorption 
of gabapentin by the digestive tract. This drug 
should be stored at room temperature, away from 
direct light and places that have moisture. 
Gabapentin given for neuropathy or pain therapy in 
the off label category is given an initial dose: 300 
mg orally on the first day, 300 mg orally twice a day 
on the second day, then 300 mg orally 3 times a day 
on the third day. Gabapentin as an off-label 
category is also mostly used to help treat patients 
who experience nerve dysfunction (tingling), feel 
punctured or pain medication or pain as a substitute 
for opioid therapy. Likewise, the administration of 
drugs with the composition of Amitriptylin 6.25 mg, 
Paracetamol 500 mg, Diazepam 1 mg, Coffein 20 
mg and the composition of Codein, Paracetamol as 
an off label category for pain therapy 
Risperidone for the on label category is used as a 
drug to treat psychiatric disorders (antipsychotics) 
such as schizophrenia or bipolar disorder. 
Risperidone can increase blood sugar, even if the 
patient does not have diabetes, so people with 
mental disorders are more at risk of developing 
diabetes. The initial dose is 2 mg per day, which can 
be increased to 4 mg per day on the second day. 
Medication can be given once a day or divided into 
two consumption schedules. The treatment dose is 
4-6 mg per day. The maximum dose is 16 mg per 
day. 
Although the use of risperidone as an off label 
category for hyperactivity therapy is still low and the 
evidence base is still small, the choice of this drug 
by clinicians is used for that therapy. 
 
Cyproheptadin is the most commonly used by 
people for appetite enhancement and usually the 
drug is combined with dexamethasone. 
Ciproheptadine is an allergy medicine that belongs 
to an antihistamine group that works to inhibit the 
release of histamine (H1) as a trigger for allergies. 
Ciproheptadine is used for the off label category as 
a drug of choice for appetite enhancer, although it 
has not been scientifically proven.  
 
CONCLUSION 
Based on the results of research and analysis of the 
Discussion of the Use of Off Label Categories of 
Medicines for Inpatients in Hospitals, this study can 
be concluded as follows: 
1. Indications of diseases using off-label categories 
of drugs are not dominated by one particular 
disease but rather based on the needs and 
conditions of the disease and the drugs available 
off-label drugs 
2. The pattern of treatment using off-label 
categories of drugs is given orally most doniman 
given by clinicians 
3. The type of drug that is commonly used in the 
off-label category is not dominated by certain 
classifications, but drugs with indicated anti-pain 
are the choice for the type of drug used 
4. The reason the clinician decides to use off-label 
category drugs is because the on-label category 
drugs have not been able to contribute to healing 
the diagnosis of the disease while some drugs 
based on experience for drugs that have not 
been approved can provide a significant healing 
process. 
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